Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis "ATIS-NVAF"

Recruiting

Phase 4 Results N/A

Summary of Purpose

The Purpose of this open-label randomized controlled multicenter trial is to evaluate the efficacy and safety of mono-drug therapy with oral anticoagulant compared to combination therapy with antiplatelet drug, in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 September 2017.

6 Apr 2017 8 Feb 2017 31 Jan 2021 31 Jan 2021 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts